![6JR 6JR](https://data.pdbj.org/pdbjplus/data/cc/svg/6JR.svg) | 6JR | 表記: | 3-[(2S,4aR,6R,7R,7aS)-2,7-dihydroxy-2-oxotetrahydro-2H,4H-2lambda~5~-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]-6-phenyl-3,4-dihydro-9H-imidazo[1,2-a]purin-9-one | 組成式: | C18 H16 N5 O7 P | SMILES: | n54C(c3ncn(C2OC1COP(OC1C2O)(O)=O)c3Nc4nc(c5)c6ccccc6)=O | InChi: | InChI=1S/C18H16N5O7P/c24-13-14-11(7-28-31(26,27)30-14)29-17(13)23-8-19-12-15(23)21-18-20-10(6-22(18)16(12)25)9-4-2-1-3-5-9/h1-6,8,11,13-14,17,24H,7H2,(H,20,21)(H,26,27)/t11-,13-,14-,17-/m1/s1 | 別名: | PET-cGMP | 定義日: | 2016-04-19 | 最終更新日: | 2021-03-01 | 公開日: | 2017-08-09 | 識別子(ID): | 3-[(2S,4aR,6R,7R,7aS)-2,7-dihydroxy-2-oxotetrahydro-2H,4H-2lambda~5~-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]-6-phenyl-3,4-dihydro-9H-imidazo[1,2-a]purin-9-one |
|
![6L4 6L4](https://data.pdbj.org/pdbjplus/data/cc/svg/6L4.svg) | 6L4 | 表記: | ~{N}-[2-[5-chloranyl-2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide | 組成式: | C17 H15 Cl N6 O2 | SMILES: | Cn1cc(Nc2ncc(Cl)c(Oc3ccccc3NC(=O)C=C)n2)cn1 | InChi: | InChI=1S/C17H15ClN6O2/c1-3-15(25)22-13-6-4-5-7-14(13)26-16-12(18)9-19-17(23-16)21-11-8-20-24(2)10-11/h3-10H,1H2,2H3,(H,22,25)(H,19,21,23) | 別名: | N-(2-((5-chloro-2-((1-methyl-1H-pyrazol-4-yl)amino)pyrimidin-4-yl)oxy)phenyl)acrylamide | 定義日: | 2016-04-26 | 最終更新日: | 2021-03-01 | 公開日: | 2017-02-15 | 識別子(ID): | ~{N}-[2-[5-chloranyl-2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide |
|
![6LD 6LD](https://data.pdbj.org/pdbjplus/data/cc/svg/6LD.svg) | 6LD | 表記: | Sacubitrilat | 組成式: | C22 H25 N O5 | SMILES: | c1(ccc(CC(NC(CCC(=O)O)=O)CC(C)C(O)=O)cc1)c2ccccc2 | InChi: | InChI=1S/C22H25NO5/c1-15(22(27)28)13-19(23-20(24)11-12-21(25)26)14-16-7-9-18(10-8-16)17-5-3-2-4-6-17/h2-10,15,19H,11-14H2,1H3,(H,23,24)(H,25,26)(H,27,28)/t15-,19+/m1/s1 | 別名: | LBQ657 | 定義日: | 2016-04-29 | 最終更新日: | 2021-03-01 | 公開日: | 2016-06-15 | 識別子(ID): | (2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-[(3-carboxypropanoyl)amino]-2-methylpentanoic acid |
|
![6O2 6O2](https://data.pdbj.org/pdbjplus/data/cc/svg/6O2.svg) | 6O2 | 表記: | [(2~{R},3~{S},4~{R},5~{R})-5-[6-[(3-ethynylphenyl)amino]purin-9-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methyl sulfamate | 組成式: | C18 H18 N6 O6 S | SMILES: | N[S](=O)(=O)OC[CH]1O[CH]([CH](O)[CH]1O)n2cnc3c(Nc4cccc(c4)C#C)ncnc23 | InChi: | InChI=1S/C18H18N6O6S/c1-2-10-4-3-5-11(6-10)23-16-13-17(21-8-20-16)24(9-22-13)18-15(26)14(25)12(30-18)7-29-31(19,27)28/h1,3-6,8-9,12,14-15,18,25-26H,7H2,(H2,19,27,28)(H,20,21,23)/t12-,14-,15-,18-/m1/s1 | 別名: | ABPA3 | 定義日: | 2016-05-30 | 最終更新日: | 2021-03-01 | 公開日: | 2017-06-14 | 識別子(ID): | [(2~{R},3~{S},4~{R},5~{R})-5-[6-[(3-ethynylphenyl)amino]purin-9-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methyl sulfamate |
|
![6PH 6PH](https://data.pdbj.org/pdbjplus/data/cc/svg/6PH.svg) | 6PH | 表記: | (1R)-2-(phosphonooxy)-1-[(tridecanoyloxy)methyl]ethyl pentadecanoate | 組成式: | C31 H61 O8 P | SMILES: | O=P(O)(OCC(OC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC)O | InChi: | InChI=1S/C31H61O8P/c1-3-5-7-9-11-13-15-16-18-20-22-24-26-31(33)39-29(28-38-40(34,35)36)27-37-30(32)25-23-21-19-17-14-12-10-8-6-4-2/h29H,3-28H2,1-2H3,(H2,34,35,36)/t29-/m1/s1 | 別名: | PHOSPHATIDIC ACID | 定義日: | 2008-04-30 | 最終更新日: | 2021-03-01 | 識別子(ID): | (1R)-2-(phosphonooxy)-1-[(tridecanoyloxy)methyl]ethyl pentadecanoate |
|
![6QC 6QC](https://data.pdbj.org/pdbjplus/data/cc/svg/6QC.svg) | 6QC | 表記: | ~{N}-[(2~{S})-1-[[(2~{R})-2,3-dimethylbutyl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]-(phenylmethoxycarbonylaminomethyl)phosphonamidic acid | 組成式: | C21 H36 N3 O5 P | SMILES: | CC(C)C[CH](N[P](O)(=O)CNC(=O)OCc1ccccc1)C(=O)NC[CH](C)C(C)C | InChi: | InChI=1S/C21H36N3O5P/c1-15(2)11-19(20(25)22-12-17(5)16(3)4)24-30(27,28)14-23-21(26)29-13-18-9-7-6-8-10-18/h6-10,15-17,19H,11-14H2,1-5H3,(H,22,25)(H,23,26)(H2,24,27,28)/t17-,19-/m0/s1 | 別名: | JC148 | 定義日: | 2016-05-23 | 最終更新日: | 2021-03-01 | 公開日: | 2016-12-21 | 識別子(ID): | ~{N}-[(2~{S})-1-[[(2~{R})-2,3-dimethylbutyl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]-(phenylmethoxycarbonylaminomethyl)phosphonamidic acid |
|
![6QD 6QD](https://data.pdbj.org/pdbjplus/data/cc/svg/6QD.svg) | 6QD | 表記: | 5-(6-oxidanylidene-3~{H}-purin-9-yl)pentylphosphonic acid | 組成式: | C10 H15 N4 O4 P | SMILES: | O[P](O)(=O)CCCCCn1cnc2C(=O)N=CNc12 | InChi: | InChI=1S/C10H15N4O4P/c15-10-8-9(11-6-12-10)14(7-13-8)4-2-1-3-5-19(16,17)18/h6-7H,1-5H2,(H,11,12,15)(H2,16,17,18) | 別名: | 9-[5-(phosphonoheptyl]hypoxanthine | 定義日: | 2016-05-23 | 最終更新日: | 2021-03-01 | 公開日: | 2016-11-09 | 識別子(ID): | 5-(6-oxidanylidene-3~{H}-purin-9-yl)pentylphosphonic acid |
|
![6RH 6RH](https://data.pdbj.org/pdbjplus/data/cc/svg/6RH.svg) | 6RH | 表記: | 4-(6-oxidanylidene-1~{H}-purin-9-yl)butylphosphonic acid | 組成式: | C9 H13 N4 O4 P | SMILES: | O[P](O)(=O)CCCCn1cnc2C(=O)NC=Nc12 | InChi: | InChI=1S/C9H13N4O4P/c14-9-7-8(10-5-11-9)13(6-12-7)3-1-2-4-18(15,16)17/h5-6H,1-4H2,(H,10,11,14)(H2,15,16,17) | 別名: | 9-(4-(phosphonobutil)hypoxanthine | 定義日: | 2016-06-02 | 最終更新日: | 2021-03-01 | 公開日: | 2016-11-09 | 識別子(ID): | 4-(6-oxidanylidene-1~{H}-purin-9-yl)butylphosphonic acid |
|
![6S8 6S8](https://data.pdbj.org/pdbjplus/data/cc/svg/6S8.svg) | 6S8 | 表記: | (~{Z})-~{N}-[(~{E},2~{S},3~{R})-1-[(2~{R},3~{R},4~{S},5~{R},6~{R})-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-3-oxidanyl-octadec-4-en-2-yl]octadec-9-enamide | 組成式: | C42 H79 N O8 | SMILES: | CCCCCCCCCCCCCC=C[CH](O)[CH](CO[CH]1O[CH](CO)[CH](O)[CH](O)[CH]1O)NC(=O)CCCCCCCC=CCCCCCCCC | InChi: | InChI=1S/C42H79NO8/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-38(46)43-35(34-50-42-41(49)40(48)39(47)37(33-44)51-42)36(45)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2/h17-18,29,31,35-37,39-42,44-45,47-49H,3-16,19-28,30,32-34H2,1-2H3,(H,43,46)/b18-17-,31-29+/t35-,36+,37+,39-,40-,41+,42+/m0/s1 | 別名: | N-(9Z-octadecenoyl)-1-beta-galactosyl-sphing-4-enine | 定義日: | 2016-06-13 | 最終更新日: | 2021-03-01 | 公開日: | 2017-12-13 | 識別子(ID): | (~{Z})-~{N}-[(~{E},2~{S},3~{R})-1-[(2~{R},3~{R},4~{S},5~{R},6~{R})-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-3-oxidanyl-octadec-4-en-2-yl]octadec-9-enamide |
|
![6SW 6SW](https://data.pdbj.org/pdbjplus/data/cc/svg/6SW.svg) | 6SW | 表記: | Inosine-3',5'-cyclic monophosphate | 組成式: | C10 H11 N4 O7 P | SMILES: | O[CH]1[CH]2O[P](O)(=O)OC[CH]2O[CH]1n3cnc4C(=O)NC=Nc34 | InChi: | InChI=1S/C10H11N4O7P/c15-6-7-4(1-19-22(17,18)21-7)20-10(6)14-3-13-5-8(14)11-2-12-9(5)16/h2-4,6-7,10,15H,1H2,(H,17,18)(H,11,12,16)/t4-,6-,7-,10-/m1/s1 | 別名: | cIMP | 定義日: | 2016-06-16 | 最終更新日: | 2021-03-01 | 公開日: | 2016-09-14 | 識別子(ID): | 9-[(4~{a}~{R},6~{R},7~{R},7~{a}~{S})-2,7-bis(oxidanyl)-2-oxidanylidene-4~{a},6,7,7~{a}-tetrahydro-4~{H}-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]-1~{H}-purin-6-one |
|
![6SX 6SX](https://data.pdbj.org/pdbjplus/data/cc/svg/6SX.svg) | 6SX | 表記: | Purine riboside-3',5'-cyclic monophosphate | 組成式: | C10 H11 N4 O6 P | SMILES: | O[CH]1[CH]2O[P](O)(=O)OC[CH]2O[CH]1n3cnc4cncnc34 | InChi: | InChI=1S/C10H11N4O6P/c15-7-8-6(2-18-21(16,17)20-8)19-10(7)14-4-13-5-1-11-3-12-9(5)14/h1,3-4,6-8,10,15H,2H2,(H,16,17)/t6-,7-,8-,10-/m1/s1 | 別名: | cPuMP | 定義日: | 2016-06-16 | 最終更新日: | 2021-03-01 | 公開日: | 2016-09-14 | 識別子(ID): | (4~{a}~{R},6~{R},7~{R},7~{a}~{S})-2-oxidanyl-2-oxidanylidene-6-purin-9-yl-4~{a},6,7,7~{a}-tetrahydro-4~{H}-furo[3,2-d][1,3,2]dioxaphosphinin-7-ol |
|
![6SZ 6SZ](https://data.pdbj.org/pdbjplus/data/cc/svg/6SZ.svg) | 6SZ | 表記: | 2-Aminopurine riboside-3',5'-cyclic monophosphate | 組成式: | C10 H12 N5 O6 P | SMILES: | Nc1ncc2ncn([CH]3O[CH]4CO[P](O)(=O)O[CH]4[CH]3O)c2n1 | InChi: | InChI=1S/C10H12N5O6P/c11-10-12-1-4-8(14-10)15(3-13-4)9-6(16)7-5(20-9)2-19-22(17,18)21-7/h1,3,5-7,9,16H,2H2,(H,17,18)(H2,11,12,14)/t5-,6-,7-,9-/m1/s1 | 別名: | 2-NH2-cPuMP | 定義日: | 2016-06-16 | 最終更新日: | 2021-03-01 | 公開日: | 2016-09-14 | 識別子(ID): | (4~{a}~{R},6~{R},7~{R},7~{a}~{S})-6-(2-azanylpurin-9-yl)-2-oxidanyl-2-oxidanylidene-4~{a},6,7,7~{a}-tetrahydro-4~{H}-furo[3,2-d][1,3,2]dioxaphosphinin-7-ol |
|
![CEI CEI](https://data.pdbj.org/pdbjplus/data/cc/svg/CEI.svg) | CEI | 表記: | N-[3-BENZYL-5-(4-HYDROXYPHENYL)PYRAZIN-2-YL]-2-(4-HYDROXYPHENYL)ACETAMIDE | 組成式: | C25 H21 N3 O3 | SMILES: | O=C(Nc1ncc(nc1Cc2ccccc2)c3ccc(O)cc3)Cc4ccc(O)cc4 | InChi: | InChI=1S/C25H21N3O3/c29-20-10-6-18(7-11-20)15-24(31)28-25-22(14-17-4-2-1-3-5-17)27-23(16-26-25)19-8-12-21(30)13-9-19/h1-13,16,29-30H,14-15H2,(H,26,28,31) | 別名: | COELENTERAMIDE | 定義日: | 2004-01-26 | 最終更新日: | 2021-03-01 | 識別子(ID): | N-[3-benzyl-5-(4-hydroxyphenyl)pyrazin-2-yl]-2-(4-hydroxyphenyl)acetamide |
|
![CFB CFB](https://data.pdbj.org/pdbjplus/data/cc/svg/CFB.svg) | CFB | 表記: | 2-CHLORO-9-(2-DEOXY-2-FLUORO-B -D-ARABINOFURANOSYL)-9H-PURIN-6-AMINE | 組成式: | C10 H11 Cl F N5 O3 | SMILES: | Clc1nc(c2ncn(c2n1)C3OC(C(O)C3F)CO)N | InChi: | InChI=1S/C10H11ClFN5O3/c11-10-15-7(13)5-8(16-10)17(2-14-5)9-4(12)6(19)3(1-18)20-9/h2-4,6,9,18-19H,1H2,(H2,13,15,16)/t3-,4+,6-,9-/m1/s1 | 別名: | CLOFARABINE | 定義日: | 2005-07-14 | 最終更新日: | 2021-03-01 | 識別子(ID): | 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-9H-purin-6-amine |
|
![CFE CFE](https://data.pdbj.org/pdbjplus/data/cc/svg/CFE.svg) | CFE | 表記: | (8R)-3-beta-D-ribofuranosyl-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol | 組成式: | C11 H16 N4 O5 | SMILES: | OC[CH]1O[CH]([CH](O)[CH]1O)n2cnc3[CH](O)CNC=Nc23 | InChi: | InChI=1S/C11H16N4O5/c16-2-6-8(18)9(19)11(20-6)15-4-14-7-5(17)1-12-3-13-10(7)15/h3-6,8-9,11,16-19H,1-2H2,(H,12,13)/t5-,6-,8-,9-,11-/m1/s1 | 別名: | Coformycin | 定義日: | 2010-01-26 | 最終更新日: | 2021-03-01 | 識別子(ID): | (2R,3R,4S,5R)-2-[(8R)-8-hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]diazepin-3-yl]-5-(hydroxymethyl)oxolane-3,4-diol |
|
![CGO CGO](https://data.pdbj.org/pdbjplus/data/cc/svg/CGO.svg) | CGO | 表記: | sodium 3,3'-(1E,1'E)-biphenyl-4,4'-diylbis(diazene-2,1-diyl)bis(4-aminonaphthalene-1-sulfonate) | 組成式: | C32 H22 N6 Na2 O6 S2 | SMILES: | [Na+][O-]S(=O)(=O)c5cc(/N=N/c1ccc(cc1)c4ccc(/N=N/c3c(c2ccccc2c(c3)S(=O)(=O)[O-][Na+])N)cc4)c(N)c6c5cccc6 | InChi: | InChI=1S/C32H24N6O6S2.2Na/c33-31-25-7-3-1-5-23(25)29(45(39,40)41)17-27(31)37-35-21-13-9-19(10-14-21)20-11-15-22(16-12-20)36-38-28-18-30(46(42,43)44)24-6-2-4-8-26(24)32(28)34 | 別名: | congo red | 定義日: | 2011-04-21 | 最終更新日: | 2021-03-01 | 識別子(ID): | mu-{3,3'-[biphenyl-4,4'-diyldi(E)diazene-2,1-diyl]bis(4-aminonaphthalene-1-sulfonato-kappaO)(2-)}disodium |
|
![CGR CGR](https://data.pdbj.org/pdbjplus/data/cc/svg/CGR.svg) | CGR | 表記: | CYCLIC GUANOSINE DIPHOSPHATE-RIBOSE | 組成式: | C15 H23 N5 O14 P2 | SMILES: | O=C1C=2N3CN(C=2N=C(N)N1)C5OC(COP(=O)(O)OP(=O)(O)OCC4OC3C(O)C4O)C(O)C5O | InChi: | InChI=1S/C15H23N5O14P2/c16-15-17-11-6(12(25)18-15)19-3-20(11)14-10(24)8(22)5(33-14)2-31-36(28,29)34-35(26,27)30-1-4-7(21)9(23)13(19)32-4/h4-5,7-10,13-14,21-24H,1-3H2,(H,26,27)(H,28,29)(H3,16,17,18,25)/t4-,5-,7-,8-,9-,10-,13-,14-/m1/s1 | 別名: | CYCLIC GDP-RIBOSE | 定義日: | 2006-12-11 | 最終更新日: | 2021-03-01 | 識別子(ID): | (2R,3R,4S,5R,8S,10S,13R,14S,15R,16R)-20-amino-3,4,8,10,14,15-hexahydroxy-7,9,11,25,26-pentaoxa-1,17,19,21-tetraaza-8,10-diphosphapentacyclo[15.6.1.1~2,5~.1~13,16~.0~18,23~]hexacosa-18(23),19-dien-22-one 8,10-dioxide (non-preferred name) |
|
![CHU CHU](https://data.pdbj.org/pdbjplus/data/cc/svg/CHU.svg) | CHU | 表記: | N-(3-fluoro-4-{[4-methyl-2-oxo-7-(pyrimidin-2-yloxy)-2H-chromen-3-yl]methyl}pyridin-2-yl)-N'-methylsulfuric diamide | 組成式: | C21 H18 F N5 O5 S | SMILES: | O=S(=O)(NC)Nc1nccc(c1F)CC2=C(c4c(OC2=O)cc(Oc3ncccn3)cc4)C | InChi: | InChI=1S/C21H18FN5O5S/c1-12-15-5-4-14(31-21-25-7-3-8-26-21)11-17(15)32-20(28)16(12)10-13-6-9-24-19(18(13)22)27-33(29,30)23-2/h3-9,11,23H,10H2,1-2H3,(H,24,27) | 別名: | CH5126766 | 定義日: | 2013-10-01 | 最終更新日: | 2021-03-01 | 公開日: | 2014-06-04 | 識別子(ID): | N-(3-fluoro-4-{[4-methyl-2-oxo-7-(pyrimidin-2-yloxy)-2H-chromen-3-yl]methyl}pyridin-2-yl)-N'-methylsulfuric diamide |
|
![CIX CIX](https://data.pdbj.org/pdbjplus/data/cc/svg/CIX.svg) | CIX | 表記: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-L-leucinamide | 組成式: | C25 H42 B N3 O6 | SMILES: | O=C(NC(B(O)O)CC(C)C)C(NC(=O)C(NC(=O)OCc1ccccc1)CC(C)C)CC(C)C | InChi: | InChI=1S/C25H42BN3O6/c1-16(2)12-20(24(31)29-22(26(33)34)14-18(5)6)27-23(30)21(13-17(3)4)28-25(32)35-15-19-10-8-7-9-11-19/h7-11,16-18,20-22,33-34H,12-15H2,1-6H3,(H,27,30)(H,28,32)(H,29,31)/t20-,21-,22-/m0/s1 | 別名: | MG262 | 定義日: | 2012-08-02 | 最終更新日: | 2021-03-01 | 公開日: | 2013-06-26 | 識別子(ID): | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-L-leucinamide |
|
![CIZ CIZ](https://data.pdbj.org/pdbjplus/data/cc/svg/CIZ.svg) | CIZ | 表記: | (~{Z})-2-methylbut-2-enedioic acid | 組成式: | C5 H6 O4 | SMILES: | O=C(O)C(C)=[C@H]C(O)=O | InChi: | InChI=1S/C5H6O4/c1-3(5(8)9)2-4(6)7/h2H,1H3,(H,6,7)(H,8,9)/b3-2- | 別名: | CITRACONATE | 定義日: | 2016-07-18 | 最終更新日: | 2021-03-01 | 公開日: | 2016-07-27 | 識別子(ID): | (2Z)-2-methylbut-2-enedioic acid |
|
![CJX CJX](https://data.pdbj.org/pdbjplus/data/cc/svg/CJX.svg) | CJX | 表記: | (2R,3S,4S,5R,6R)-2-(aminomethyl)-6-[(1R,2S,3S,4R,6S)-4,6-bis(azanyl)-3-[(2S,3R,4S,5S,6R)-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-2-oxidanyl-cyclohexyl]oxy-oxane-3,4,5-triol | 組成式: | C18 H35 N3 O12 | SMILES: | NC[CH]1O[CH](O[CH]2[CH](N)C[CH](N)[CH](O[CH]3O[CH](CO)[CH](O)[CH](O)[CH]3O)[CH]2O)[CH](O)[CH](O)[CH]1O | InChi: | InChI=1S/C18H35N3O12/c19-2-6-8(23)10(25)12(27)17(30-6)32-15-4(20)1-5(21)16(14(15)29)33-18-13(28)11(26)9(24)7(3-22)31-18/h4-18,22-29H,1-3,19-21H2/t4-,5+,6+,7+,8+,9+,10-,11-,12+,13+,14-,15+,16-,17+,18+/m0/s1 | 別名: | 3"-deamino-3"-hydroxykanamycin A | 定義日: | 2019-04-25 | 最終更新日: | 2021-03-01 | 公開日: | 2020-04-15 | 識別子(ID): | (2~{R},3~{S},4~{S},5~{R},6~{R})-2-(aminomethyl)-6-[(1~{R},2~{S},3~{S},4~{R},6~{S})-4,6-bis(azanyl)-3-[(2~{S},3~{R},4~{S},5~{S},6~{R})-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-2-oxidanyl-cyclohexyl]oxy-oxane-3,4,5-triol |
|
![CK0 CK0](https://data.pdbj.org/pdbjplus/data/cc/svg/CK0.svg) | CK0 | 表記: | (2S,3R,4S,5S,6R)-2-[(1S,2S,3R,4S,6R)-3-[(2R,3R,4R,5S,6R)-6-(aminomethyl)-3-azanyl-4,5-bis(oxidanyl)oxan-2-yl]oxy-4,6-bis(azanyl)-2-oxidanyl-cyclohexyl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol | 組成式: | C18 H36 N4 O11 | SMILES: | NC[CH]1O[CH](O[CH]2[CH](N)C[CH](N)[CH](O[CH]3O[CH](CO)[CH](O)[CH](O)[CH]3O)[CH]2O)[CH](N)[CH](O)[CH]1O | InChi: | InChI=1S/C18H36N4O11/c19-2-6-9(24)11(26)8(22)17(30-6)32-15-4(20)1-5(21)16(14(15)29)33-18-13(28)12(27)10(25)7(3-23)31-18/h4-18,23-29H,1-3,19-22H2/t4-,5+,6+,7+,8+,9+,10+,11+,12-,13+,14-,15+,16-,17+,18+/m0/s1 | 別名: | 3"-deamino-3"-hydroxykanamycin B | 定義日: | 2019-04-25 | 最終更新日: | 2021-03-01 | 公開日: | 2020-04-15 | 識別子(ID): | (2~{S},3~{R},4~{S},5~{S},6~{R})-2-[(1~{S},2~{S},3~{R},4~{S},6~{R})-3-[(2~{R},3~{R},4~{R},5~{S},6~{R})-6-(aminomethyl)-3-azanyl-4,5-bis(oxidanyl)oxan-2-yl]oxy-4,6-bis(azanyl)-2-oxidanyl-cyclohexyl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol |
|
![CKA CKA](https://data.pdbj.org/pdbjplus/data/cc/svg/CKA.svg) | CKA | 表記: | 7-Chlorokynurenic acid | 組成式: | C10 H6 Cl N O3 | SMILES: | c1cc(cc2c1C(C=C(C(O)=O)N2)=O)Cl | InChi: | InChI=1S/C10H6ClNO3/c11-5-1-2-6-7(3-5)12-8(10(14)15)4-9(6)13/h1-4H,(H,12,13)(H,14,15) | 別名: | 7-CKA | 定義日: | 2015-07-02 | 最終更新日: | 2021-03-01 | 公開日: | 2015-12-29 | 識別子(ID): | 7-chloro-4-oxo-1,4-dihydroquinoline-2-carboxylic acid |
|
![CKT CKT](https://data.pdbj.org/pdbjplus/data/cc/svg/CKT.svg) | CKT | 表記: | Cys-ketimine | 組成式: | C11 H15 N2 O7 P S | SMILES: | Cc1c(c(c(cn1)COP(O)(=O)O)CN=C(C(O)=O)CS)O | InChi: | InChI=1S/C11H15N2O7PS/c1-6-10(14)8(3-13-9(5-22)11(15)16)7(2-12-6)4-20-21(17,18)19/h2,14,22H,3-5H2,1H3,(H,15,16)(H2,17,18,19)/b13-9+ | 別名: | (2Z)-2-[({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)imino]-3-sulfanylpropanoic acid | 定義日: | 2019-02-18 | 最終更新日: | 2021-03-01 | 公開日: | 2019-07-03 | 識別子(ID): | (2Z)-2-[({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)imino]-3-sulfanylpropanoic acid |
|
![CL6 CL6](https://data.pdbj.org/pdbjplus/data/cc/svg/CL6.svg) | CL6 | 表記: | 1-[(2-CHLOROPHENYL)(DIPHENYL)METHYL]-1H-IMIDAZOLE | 組成式: | C22 H17 Cl N2 | SMILES: | Clc1ccccc1C(c2ccccc2)(c3ccccc3)n4ccnc4 | InChi: | InChI=1S/C22H17ClN2/c23-21-14-8-7-13-20(21)22(25-16-15-24-17-25,18-9-3-1-4-10-18)19-11-5-2-6-12-19/h1-17H | 別名: | CLOTRIMAZOLE | 定義日: | 2006-10-26 | 最終更新日: | 2021-03-01 | 識別子(ID): | 1-[(2-chlorophenyl)(diphenyl)methyl]-1H-imidazole |
|